Indications
Treatment of hereditary transthyretin-mediated amyloidosis (ATTRv) in adult patients with stage 1 or stage 2 polyneuropathy.
Composition
- Active substance
- eplontersen sodium
- International name (INN)
- eplontersen
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Wainzua
- Active substance
- eplontersen sodium
- ATC code
- N07XX21
- Group
- Nervous system
- Therapeutic area
- Amyloid Neuropathies, Familial
- Marketing authorisation holder
- AstraZeneca AB
- Status
- Authorised